Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 6/20 | 0.53 |
| ▸ | CYP3A4 | P08684 | 4/20 | 0.53 |
| ▸ | LMNA | P02545 | 4/20 | 0.53 |
| ▸ | CYP19A1 | P11511 | 9/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 7/20 | 0.41 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.41 |
| ▸ | BLM | P54132 | 3/20 | 0.41 |
| ▸ | PMP22 | Q01453 | 3/20 | 0.41 |
| ▸ | NPSR1 | Q6W5P4 | 3/20 | 0.41 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.41 |
| ▸ | SHBG | P04278 | 2/20 | 0.41 |
| ▸ | SERPINA6 | P08185 | 2/20 | 0.41 |
| ▸ | HSD17B3 | P37058 | 2/20 | 0.41 |
| ▸ | SNCA | P37840 | 2/20 | 0.41 |
| ▸ | TSHR | P16473 | 2/20 | 0.41 |
| ▸ | SRD5A1 | P18405 | 1/20 | 0.39 |
| ▸ | SRD5A2 | P31213 | 1/20 | 0.39 |
| ▸ | POLB | P06746 | 1/20 | 0.37 |
| ▸ | NR1I2 | O75469 | 2/20 | 0.36 |
| ▸ | NR3C1 | P04150 | 2/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2618326 | 1.00 | ALDH1A1 (0.53) | ALDH1A1CYP3A4LMNACYP19A1SMN1; SMN2 | |
| SCHEMBL2549760 | 1.00 | ALDH1A1 (0.53) | ALDH1A1CYP3A4LMNACYP19A1SMN1; SMN2 | |
| SCHEMBL267262 | 0.88 | ALDH1A1 (0.46) | ALDH1A1CYP3A4LMNACYP19A1SMN1; SMN2 | |
| SCHEMBL260976 | 0.88 | ALDH1A1 (0.46) | ALDH1A1CYP3A4LMNACYP19A1SMN1; SMN2 | |
| SCHEMBL4232967 | 0.88 | ALDH1A1 (0.46) | ALDH1A1CYP3A4LMNACYP19A1SMN1; SMN2 | |
| SCHEMBL9123435 | 0.73 | ALDH1A1 (0.67) | ALDH1A1CYP3A4LMNACYP19A1TSHR | |
| SCHEMBL7789528 | 0.73 | ALDH1A1 (0.67) | ALDH1A1CYP3A4LMNACYP19A1TSHR | |
| SCHEMBL12911139 | 0.73 | ALDH1A1 (0.44) | ALDH1A1CYP3A4LMNACYP19A1SMN1; SMN2 | |
| SCHEMBL14592015 | 0.71 | ALDH1A1 (0.42) | ALDH1A1CYP3A4LMNACYP19A1SMN1; SMN2 | |
| SCHEMBL11444299 | 0.71 | CYP19A1 (0.40) | ALDH1A1CYP3A4LMNACYP19A1SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 59 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240182516-A1 | METHODS FOR CONVENIENT ASYMMETRIC SYNTHESIS OF C9-SUBSTITUTED STEROID-LIKE COMPOUNDS | TRUSTEES OF DARTMOUTH COLLEGE | 2024-06-06 | — | — | US | claimed |
| WO-2022198224-A1 | METHODS FOR CONVENIENT ASYMMETRIC SYNTHESIS OF C9-SUBSTITUTED STEROID-LIKE COMPOUNDS | TRUSTEES OF DARTMOUTH COLLEGE (US) | 2022-09-22 | — | — | WO | claimed |
| US-20240182516-A1 | METHODS FOR CONVENIENT ASYMMETRIC SYNTHESIS OF C9-SUBSTITUTED STEROID-LIKE COMPOUNDS | TRUSTEES OF DARTMOUTH COLLEGE | 2024-06-06 | — | — | US | disclosed |
| CN-118047805-A | Method for synthesizing Danishefafsky-Diene by palladium catalysis | 南京师范大学 | 2024-05-17 | — | — | CN | disclosed |
| CN-116640737-A | BsER alkene reductase and construction and application of mutant thereof | 沈阳药科大学 | 2023-08-25 | — | — | CN | disclosed |
| WO-2022198224-A1 | METHODS FOR CONVENIENT ASYMMETRIC SYNTHESIS OF C9-SUBSTITUTED STEROID-LIKE COMPOUNDS | TRUSTEES OF DARTMOUTH COLLEGE (US) | 2022-09-22 | — | — | WO | disclosed |
| US-20200331828-A1 | NOVEL COMPOUNDS WHICH ACTIVATE ESTROGEN RECEPTORS AND COMPOSITIONS AND METHODS OF USING THE SAME | UNIV ILLINOIS (US) | 2020-10-22 | — | — | US | disclosed |
| US-10716795-B2 | Steroid analogues for neuroprotection | EMORY UNIVERSITY (US) | 2020-07-21 | — | — | US | disclosed |
| US-10703698-B2 | Compounds which activate estrogen receptors and compositions and methods of using the same | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS (US) | 2020-07-07 | — | — | US | disclosed |
| US-20190002380-A1 | NOVEL COMPOUNDS WHICH ACTIVATE ESTROGEN RECEPTORS AND COMPOSITIONS AND METHODS OF USING THE SAME | THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS | 2019-01-03 | — | — | US | disclosed |
| EP-3400071-A1 | NOVEL COMPOUNDS WHICH ACTIVATE ESTROGEN RECEPTORS AND COMPOSITIONS AND METHODS OF USING THE SAME | The Board of Trustees of the University of Illinois (US) | 2018-11-14 | — | — | EP | disclosed |
| US-4108898-A | Asymmetric synthesis of organic compounds | HOFFMANN-LA ROCHE INC. (US) | 1978-08-22 | — | — | US | disclosed |
| US-4105696-A | Asymmetric synthesis of organic compounds | HOFFMANN-LA ROCHE INC. (US) | 1978-08-08 | — | — | US | disclosed |
| US-4102929-A | Asymmetric synthesis of organic compounds | HOFFMANN-LA ROCHE INC. (US) | 1978-07-25 | — | — | US | disclosed |
| US-4072716-A | Bicycloalkane derivatives | SCHERING AKTIENGESELLSCHAFT (DT) | 1978-02-07 | — | — | US | disclosed |
| US-4051188-A | NOVEL BICYCLOALKANE DERIVATIVES AND THE PRODUCTION THEREOF | SCHERING AKTIENGESELLSCHAFT (DT) | 1977-09-27 | — | — | US | disclosed |
| US-4024166-A | Process for the preparation of 13β-alkyl-4-gonene-3,17-diones | SCHERING AKTIENGESELLSCHAFT (DT) | 1977-05-17 | — | — | US | disclosed |
| US-4008253-A | Bicycloalkanes | SCHERING AKTIENGESELLSCHAFT (DT) | 1977-02-15 | — | — | US | disclosed |
| US-3975440-A | Asymmetric synthesis of organic compounds | HOFFMANN-LA ROCHE INC. (US) | 1976-08-17 | — | — | US | disclosed |
| US-3975442-A | STEROID INTERMEDIATES | HOFFMANN-LA ROCHE INC. (US) | 1976-08-17 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10703698-B2 | Compounds which activate estrogen receptors and compositions and methods of using the same | GPER1, ESRRG, ESR2 | ALDH1A1 2046/4885CYP3A4 1153/4885LMNA 4049/4885 |
| US-20190002380-A1 | NOVEL COMPOUNDS WHICH ACTIVATE ESTROGEN RECEPTORS AND COMPOSITIONS AND METHODS OF USING THE SAME | GPER1, ESRRG, ESR2 | ALDH1A1 2074/4885CYP3A4 1033/4885LMNA 4400/4885 |
| US-20200331828-A1 | NOVEL COMPOUNDS WHICH ACTIVATE ESTROGEN RECEPTORS AND COMPOSITIONS AND METHODS OF USING THE SAME | GPER1, ESRRG, ESR2 | ALDH1A1 2074/4885CYP3A4 1033/4885LMNA 4400/4885 |
| US-20240182516-A1 | METHODS FOR CONVENIENT ASYMMETRIC SYNTHESIS OF C9-SUBSTITUTED STEROID-LIKE COMPOUNDS | C9, HSD17B7, CYP11A1 | ALDH1A1 3578/4885CYP3A4 529/4885LMNA 1924/4885 |
| US-10716795-B2 | Steroid analogues for neuroprotection | CYP11A1, NR3C2, HSD17B7 | ALDH1A1 3178/4885CYP3A4 1956/4885LMNA 831/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.